Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masashi Maeda

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Pharmacological Sciences|December 23, 2008
Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeysFumitaka Kinugasa, Itsuo Nagatomi, Hirofumi Ishikawa, et al.
International Immunopharmacology|September 10, 2018
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primatesKoji Nakamura, Shinsuke Oshima, Masashi Maeda, et al.
Cancer Research|July 23, 2013
Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signalingRina Kanda, Akihiko Kawahara, Kosuke Watari, et al.
Transplant Immunology|October 10, 2017
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation modelKoji Nakamura, Yuka Kawato, Yoko Kaneko, et al.
Journal of Pharmaceutical Sciences|June 14, 2022
Preclinical Characterization of ASP2713, a Novel Igβ and FcγRIIB Cross-Linking Antibody, for Prediction of Human Pharmacokinetics and Clinically Effective DoseKentaro Konishi, Koji Nakamura, Yuichi Hanada, et al.
Transplant Immunology|August 23, 2016
A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapyKaori Hanaoka, Yuka Kawato, Kaori Kubo, et al.
International Immunopharmacology|November 15, 2021
Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosusYukihiro Kitanaga, Daisuke Yamajuku, Satoshi Kubo, et al.
Transplantation|November 19, 2016
The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman PrimatesShinsuke Oshima, Erik E Karrer, Yuka Kawato, et al.
Nature Communications|June 17, 2025
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitisAtsuo Kanno, Takuya Kito, Masashi Maeda, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Pharmacological Sciences|December 23, 2008
Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeysFumitaka Kinugasa, Itsuo Nagatomi, Hirofumi Ishikawa, et al.
International Immunopharmacology|September 10, 2018
Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primatesKoji Nakamura, Shinsuke Oshima, Masashi Maeda, et al.
Cancer Research|July 23, 2013
Erlotinib resistance in lung cancer cells mediated by integrin β1/Src/Akt-driven bypass signalingRina Kanda, Akihiko Kawahara, Kosuke Watari, et al.
Transplant Immunology|October 10, 2017
Prevention of chronic renal allograft rejection by AS2553627, a novel JAK inhibitor, in a rat transplantation modelKoji Nakamura, Yuka Kawato, Yoko Kaneko, et al.
Journal of Pharmaceutical Sciences|June 14, 2022
Preclinical Characterization of ASP2713, a Novel Igβ and FcγRIIB Cross-Linking Antibody, for Prediction of Human Pharmacokinetics and Clinically Effective DoseKentaro Konishi, Koji Nakamura, Yuichi Hanada, et al.
Transplant Immunology|August 23, 2016
A chronic renal rejection model with a fully MHC-mismatched rat strain combination under immunosuppressive therapyKaori Hanaoka, Yuka Kawato, Kaori Kubo, et al.
International Immunopharmacology|November 15, 2021
Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosusYukihiro Kitanaga, Daisuke Yamajuku, Satoshi Kubo, et al.
Transplantation|November 19, 2016
The Effect of ASP2409, a Novel CD86-Selective Variant of CTLA4-Ig, on Renal Allograft Rejection in Nonhuman PrimatesShinsuke Oshima, Erik E Karrer, Yuka Kawato, et al.
Nature Communications|June 17, 2025
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitisAtsuo Kanno, Takuya Kito, Masashi Maeda, et al.
Pageof 4